PTBP2 and pancreatic adenocarcinoma: We finally identified PTBP1 in ACC, KIRP, and LGG; PTBP2 in ACC and KICH; and PTBP3 in ACC, LGG, and PAAD as potential prognostic biomarkers that may be involved in tumor progression in these tumor types.